A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus

Mark W. Kline(Tulane University), Cara Simon(Baylor College of Medicine), Courtney V. Fletcher(University of Nebraska at Omaha), Suzanne Kirkpatrick(Baylor College of Medicine), Alice T. Harris(Baylor College of Medicine), Nancy R. Calles(Texas Children's Hospital), Kim D. Evans(Baylor College of Medicine), Rory P. Remmel(University of Minnesota), Richard C. Brundage(MelroseWakefield Healthcare)
The Journal of Pediatrics
March 1, 1998
Cited by 60


Related Papers